Breaking Down the Current Politics of Federal Prescription Drug Reform

Tired of legalese and political jargon surrounding federal prescription drug reform? This episode dives deep into President Trump’s recent healthcare reform Executive Order and what it really means for patients and their pharmacies. We’ll untangle topics like:

• The truth behind IRA drug price negotiations and how they could impact pharmacies and ultimately, patient access.  
• Why Medicare and Long Term Care pricing continues to be a battleground. 
• How prescription drug rebates under current Safe Harbor laws create more problems than solutions.  
• The shocking facts behind drug pricing disparities and their real-world consequences.  
• The ongoing battle for PBM reform - and what could lie ahead.

We’re joined by Mark Boesen, J.D., PharmD, of Boesen & Snow Law, who brings his expertise in pharmaceutical law, policy, and advocacy to help us decode the political language. Together, we discuss who could benefit and who could be harmed - because when it comes down to it, prescription drug reform and PBM reform are 2 sides of the same coin.

Music by cat_herding_diva | Production & Editing by Shannon Wightman-Girard